Skip to main content
TipRanks
Go Ultimate75% OFF

Baker Bros. Advisors Lp Insider Profile

235 Followers

Baker Bros. Advisors Lp, Director at Madrigal Pharmaceuticals, holds 2.24M shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 20.42M shares in Kodiak Sciences (Ticker: KOD), holds 4.37M shares in Celcuity (Ticker: CELC). Most recently, Baker Bros. Advisors Lp Bought ― shares of Madrigal Pharmaceuticals on Nov 06, 2026 for an estimated value of $35.02M.

Baker Bros. Advisors Lp's Trading History

KOD
Kodiak Sciences
Nov 06, 2026Director, Ten Percent OwnerInformative Buy24.34M$2.27B
MDGL
Madrigal Pharmaceuticals
Nov 06, 2026DirectorInformative Buy35.02M$959.24M
CELC
Celcuity
Jul 16, 2026Former 10% ownerInformative Sell317.75M$281.48M
INCY
Incyte
Jul 02, 2026Director, Ten Percent OwnerUninformative Buy―$3.48B
ONC
BeOne Medicines
Jun 15, 2026DirectorUninformative Buy―$3.74B
DNLI
Denali Therapeutics
Jun 05, 2026DirectorUninformative Buy―$64.14M
ACAD
ACADIA Pharmaceuticals
Jun 02, 2026Director, Ten Percent OwnerUninformative Buy―$742.32M
KNSA
Kiniksa Pharmaceuticals
Jun 02, 2026DirectorUninformative Buy―$267.27M
BCYC
Bicycle Therapeutics
Jan 06, 2026Director, Ten Percent OwnerUninformative Buy―$33.76M
KYMR
Kymera Therapeutics
Dec 11, 2025Director, Ten Percent OwnerInformative Buy172.50M$1.01B
TRDA
Entrada Therapeutics Inc
Nov 24, 2025Ten Percent OwnerInformative Buy261.68K$23.88M
KALA
KALA BIO
Oct 02, 2025Former 10% ownerInformative Sell1.05M$58.65K
VTVT
vTv Therapeutics
Sep 05, 2025DirectorUninformative Buy―$2.68M
IGMS
IGM Biosciences
Aug 18, 2025―Uninformative Sell―$0.00
IMCR
Immunocore Holdings
Mar 19, 2025DirectorInformative Buy23.99M$64.19M
BLCM
Bellicum Pharmaceuticals
Nov 24, 2023―Uninformative Buy―$160.49K
BCEL
Atreca
Oct 23, 2023―Informative Sell109.90K$267.40K
NGNE
Neurogene
Oct 10, 2023Director, Former 10% OwnerUninformative Buy―$10.86M
SGEN
Seagen
Jun 02, 2023―Uninformative Buy―$9.84B
DBVT
DBV Technologies SA - American
Jun 13, 2022DirectorUninformative Buy―$321.53M
TCRX
TScan Therapeutics
May 12, 2022DirectorInformative Buy2.56M$404.57K
TLIS
Talis Biomedical
Nov 19, 2021―Informative Buy218.00K$21.66M
PRLD
Prelude Therapeutics
Jan 29, 2021Director, Ten Percent OwnerUninformative Buy133.33K$31.92M
ALXN
Alexion Pharmaceuticals
May 18, 2020―Uninformative Buy―$1.47B
GHDX
Genomic Health
Oct 03, 2019―Uninformative Buy124.47K$484.81M
ACGN
Aceragen
Jul 03, 2019―Uninformative Buy15.47K$1.65M
HOOK
Hookipa Pharma
Apr 23, 2019―Informative Buy12.50M$943.84K
NVTAQ
Invitae
Mar 29, 2018―Informative Buy5.00M$83.09K
MRTX
Mirati Therapeutics
Nov 13, 2017―Informative Buy2.20M$2.13M
BCRX
BioCryst
Aug 16, 2016Ten Percent OwnerInformative Sell20.25M$114.63M
XOMA
XOMA Royalty Corporation
Jul 23, 2015―Informative Sell11.99M$3.64M
GEVA
Synageva
――――
REPL
Replimune Group
―Director, Ten Percent Owner――
ZYME
Zymeworks
―Director――
SYRE
Spyre Therapeutics
―Director――

You May Also Like

Baker Bros. Advisors Lp insider profile FAQ

What is the percentage of profitable transactions made by Baker Bros. Advisors Lp?
The percentage of profitable transactions made by Baker Bros. Advisors Lp is 56%.
What is the average return per transaction made by Baker Bros. Advisors Lp?
The average return per transaction made by Baker Bros. Advisors Lp is 29.90%.
What stocks does Baker Bros. Advisors Lp hold?
Baker Bros. Advisors Lp holds: MDGL, ALXN, BCRX, ACGN, DBVT, BLCM, VTVT, ONC, SYRE, ZYME, KALA, CELC, DNLI, KNSA, REPL, KOD, HOOK, BCYC, BCEL, IGMS, KYMR, PRLD, IMCR, TLIS, TCRX, TRDA, MRTX, NGNE, NVTAQ, ACAD, XOMA, GHDX, INCY, SGEN, GEVA stocks.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp’s latest transaction was an Informative Buy of $35.02M.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in Madrigal Pharmaceuticals?
Baker Bros. Advisors Lp's role in Madrigal Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.